INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 24 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,800 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,800 | -2.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $9,000 | -10.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +14.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | -12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | -20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $56,098,000 | 1.12% |
| L & S Advisors Inc | 795,000 | $767,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 9,964,000 | $9,690,000 | 0.11% |
| WEDBUSH SECURITIES INC | 13,000 | $1,251,000 | 0.07% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,163,000 | $3,076,000 | 0.06% |
| ZAZOVE ASSOCIATES LLC | 246,000 | $240,000 | 0.02% |
| Balboa Wealth Partners | 21,000 | $20 | 0.01% |
| Russell Investments Group, Ltd. | 1,910,000 | $1,875,000 | 0.00% |
| GAMCO INVESTORS, INC. ET AL | 250,000 | $244,000 | 0.00% |
| Regal Investment Advisors LLC | 20,000 | $19,000 | 0.00% |